Tom Cosgrove is the Director of the Office of Manufacturing Quality (OMQ) within FDA’s Center for Drug Evaluation and Research (CDER). In this role, he directs CDER’s compliance activities with respect to CGMP and product quality. Before OMQ, Tom led CDER’s Office of Unapproved Drugs and Labelling Compliance (OUDLC), where he was responsible for FDA’s compliance divisions covering drug approval and labelling issues. Before joining CDER, Tom was a litigator in FDA’s Office of Chief Counsel, and prior to FDA, Tom was an attorney at Covington & Burling in Washington, D.C. Tom clerked for Judge Catherine Blake on the United States District Court for the District of Maryland and earned his law degree from The University of Michigan Law School.
Subscribe to our blogs
Get alerts for latest posts